Abstract
We describe the emergence of an azithromycin-resistant Neisseria gonorrhoeae variant in a man from Portland, Oregon, during sole treatment with 2 g azithromycin. This report highlights the ease with which gonococcal macrolide resistance can emerge, the threat of multidrug resistant N. gonorrhoeae, and the need for adherence to Centers for Disease Control and Prevention treatment guidelines.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / pharmacology*
-
Azithromycin / pharmacology*
-
Centers for Disease Control and Prevention, U.S.
-
Drug Resistance, Bacterial / drug effects
-
Genotype
-
Gonorrhea / drug therapy*
-
Gonorrhea / epidemiology
-
Guideline Adherence
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Neisseria gonorrhoeae / drug effects*
-
Neisseria gonorrhoeae / isolation & purification*
-
Oregon
-
United States
Substances
-
Anti-Bacterial Agents
-
Azithromycin